GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » Pre-Tax Income

Panacea Biotec (BOM:531349) Pre-Tax Income : ₹-286 Mil (TTM As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Panacea Biotec's pretax income for the three months ended in Jun. 2024 was ₹-171 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jun. 2024 was ₹-286 Mil. Panacea Biotec's pretax margin was -14.73%.

During the past 13 years, Panacea Biotec's highest Pretax Margin was 219.86%. The lowest was -31.87%. And the median was -6.39%.


Panacea Biotec Pre-Tax Income Historical Data

The historical data trend for Panacea Biotec's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacea Biotec Pre-Tax Income Chart

Panacea Biotec Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,712.20 -1,442.46 14,493.56 128.05 14.77

Panacea Biotec Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.30 -77.80 -16.50 -21.23 -170.50

Competitive Comparison of Panacea Biotec's Pre-Tax Income

For the Biotechnology subindustry, Panacea Biotec's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Panacea Biotec's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's Pre-Tax Income falls into.



Panacea Biotec Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Panacea Biotec's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-442.22+0+-26.73+83.73+399.99
=15

Panacea Biotec's Pretax Income for the quarter that ended in Jun. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-227.2+0+-8.7+0+65.4
=-171

Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-286 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacea Biotec  (BOM:531349) Pre-Tax Income Explanation

Panacea Biotec's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-170.5/1157.2
=-14.73%

During the past 13 years, Panacea Biotec's highest Pretax Margin was 219.86%. The lowest was -31.87%. And the median was -6.39%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacea Biotec Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacea Biotec Business Description

Traded in Other Exchanges
Address
Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044
Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec Headlines

No Headlines